About the Study

Respiratory syncytial virus (RSV): An study treatment for RSV

This study is being done for children: • Ages 28 days to 36 months • Can be in the study for around 29 days • Hospitalized or non-hospitalized The purpose of this research study is to obtain information on how effective and how safe the Study Drug is in treating children with RSV infection and to determine the dose of Study Drug that works best. This will be done by checking how the children are feeling, and any side effects or changes to the children's laboratory tests.

Interested in learning more?

Full Study Name: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-PART STUDY TO EVALUATE EDP-938 REGIMENS IN SUBJECTS AGED 28 DAYS TO 36 MONTHS INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS (RSV)